Publications (12) ELADIO ANDRES VELASCO SAMPEDRO publications

filter_list

2025

  1. β2-Chimaerin Deficiency Favors Polyp Growth in the Colon of ApcMin/+ Mice

    Molecules, Vol. 30, Núm. 4

2024

  1. Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants

    Journal of Pathology, Vol. 262, Núm. 4, pp. 395-409

  2. Splicing Dysregulation of Non-Canonical GC-5′ Splice Sites of Breast Cancer Susceptibility Genes ATM and PALB2

    Cancers, Vol. 16, Núm. 21

  3. β2-Chimaerin, a GTPase-Activating Protein for Rac1, Is a Novel Regulator of Hepatic Insulin Signaling and Glucose Metabolism

    Molecules, Vol. 29, Núm. 22

2022

  1. Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants

    Journal of Pathology, Vol. 258, Núm. 1, pp. 83-101

2020

  1. Editorial: RNA Splicing and Backsplicing: Disease and Therapy

    Frontiers in Genetics

2019

  1. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays

    Journal of Pathology, Vol. 248, Núm. 4, pp. 409-420

2018

  1. Functional analyses of a novel splice variant in the CHD7 gene, found by next generation sequencing, confirm its pathogenicity in a Spanish patient and diagnose him with CHARGE syndrome

    Frontiers in Genetics, Vol. 9, Núm. JAN

  2. Identification of eight spliceogenic variants in BRCA2 Exon 16 by minigene assays

    Frontiers in Genetics, Vol. 9, Núm. MAY

2017

  1. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18

    PLoS Genetics, Vol. 13, Núm. 3

2015

  1. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons

    Human Mutation, Vol. 36, Núm. 2, pp. 210-221

2005

  1. Mutaciones en BRCA1 y BRCA2 en pacientes con historia familiar de cáncer de mama

    Medicina Clinica, Vol. 124, Núm. 1, pp. 10-12